Cyclodextrin host-guest complex to facilitate sinomenine-based osteoporosis therapy
Meng-Qin Guo,
No information about this author
Ping Hu,
No information about this author
Zhi-hong Huang
No information about this author
et al.
World Journal of Stem Cells,
Journal Year:
2025,
Volume and Issue:
17(3)
Published: March 19, 2025
Xiao
et
al
reported
on
the
natural
product
sinomenine
(SIN),
which
is
a
traditional
Chinese
medicine
for
treating
osteoporosis
via
its
modulation
of
autophagy;
however,
SIN
was
dissolved
in
dimethyl
sulfoxide
prior
to
administration,
not
conducive
development
clinical
injectables.
By
comparing
solubilization
techniques,
including
amorphisation,
emulsification,
micellisation,
nano-crystallisation
and
host-guest
inclusion,
we
found
that
by
inclusion
can
enhance
solubility
improve
stability
has
an
increased
release
rate
enhanced
bioavailability.
Therefore,
conclude
holds
promise
solubilization.
To
solubilise
SIN,
selected
β-cyclodextrin
as
host
agent
considering
excellent
biocompatibility,
efficient
encapsulation
ability,
mature
preparation
process
adequate
drug
stability.
If
prerequisites
SIN-β-cyclodextrin
complexes
terms
safety,
efficacy,
relevant
laws
regulations
are
met,
application
treatment
may
be
achieved.
Language: Английский
Targeting the mTOR-Autophagy Axis: Unveiling Therapeutic Potentials in Osteoporosis
Rongjin Chen,
No information about this author
Chenhui Yang,
No information about this author
Fei Yang
No information about this author
et al.
Biomolecules,
Journal Year:
2024,
Volume and Issue:
14(11), P. 1452 - 1452
Published: Nov. 15, 2024
Osteoporosis
(OP)
is
a
widespread
age-related
disorder
marked
by
decreased
bone
density
and
increased
fracture
risk,
presenting
significant
public
health
challenge.
Central
to
the
development
progression
of
OP
dysregulation
mechanistic
target
rapamycin
(mTOR)-signaling
pathway,
which
plays
critical
role
in
cellular
processes
including
autophagy,
growth,
proliferation.
The
mTOR-autophagy
axis
emerging
as
promising
therapeutic
due
its
regulatory
capacity
metabolism
homeostasis.
This
review
aims
(1)
elucidate
mTOR
signaling
OP,
(2)
explore
interplay
between
autophagy
context
cell
activity,
(3)
assess
potential
targeting
pathway
with
modulators
innovative
strategies
for
treatment.
By
examining
interactions
among
mTOR,
insights
from
various
types
impact
on
different
cells,
this
underscores
complexity
mTOR's
health.
Despite
advances,
gaps
remain
understanding
detailed
mechanisms
effects
function,
highlighting
need
comprehensive
clinical
trials
establish
efficacy
safety
inhibitors
management.
Future
research
directions
include
clarifying
molecular
investigating
combined
benefits
modulation
other
approaches.
Addressing
these
challenges
crucial
developing
more
effective
treatments
improving
outcomes
individuals
thereby
unveiling
potentials
prevalent
disease.
Language: Английский